Performance analysis of Pieris Pharmaceuticals (PIRS)
Annual Return
Over the past 3 years, PIRS has had an average annual return of -19.20%, underperforming the benchmark SPY, which returned +24.27% annual.
Over the past 5 years, PIRS has had an average annual return of -59.08%, underperforming the benchmark SPY, which returned +11.67% annual.
Over the past 10 years, PIRS has had an average annual return of -23.86%, underperforming the benchmark SPY, which returned +14.86% annual.
Since Apr 13, 2015, PIRS has had an average annual return of -27.16%, underperforming the benchmark SPY, which returned +13.54% annual.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.61% | -82.49% | -72.49% | +51.20% | -30.94% | +36.09% | -64.77% | +437.27% | -38.64% | -37.26% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | +1.60% | -10.85% | +11.06% | -20.12% | -13.22% | -3.45% | +69.05% | +10.92% | -9.84% | +4.05% | -5.75% | -16.34% | -6.61% |
| 2023 | +53.88% | -6.25% | -34.94% | -22.59% | +12.22% | -80.50% | +33.55% | +53.72% | -12.26% | -20.34% | -13.85% | -10.89% | -82.49% |
| 2022 | -3.70% | -15.11% | -1.95% | -7.59% | -36.42% | +5.04% | -5.88% | -17.05% | -21.23% | -3.49% | -12.10% | +6.58% | -72.49% |
| 2021 | +1.61% | +7.08% | -5.52% | -15.95% | +59.26% | +11.33% | -9.14% | +54.89% | -4.08% | -11.41% | -27.95% | +14.54% | +51.20% |
| 2020 | +2.21% | -15.94% | -26.69% | +16.22% | +35.85% | -13.89% | -17.10% | +11.29% | -27.63% | +21.27% | +16.33% | -14.39% | -30.94% |
| 2019 | +7.89% | +4.53% | +11.67% | -10.74% | +38.45% | +13.53% | +17.01% | -15.45% | -26.67% | -2.93% | +22.97% | -11.06% | +36.09% |
| 2018 | -0.27% | +13.15% | -19.95% | -6.60% | -11.78% | -9.79% | +8.29% | +0.91% | +1.08% | -26.42% | -17.72% | -21.53% | -64.77% |
| 2017 | +55.84% | -6.85% | +27.45% | -7.30% | +90.03% | +10.48% | +2.77% | +5.96% | +4.54% | -12.32% | +22.38% | +22.17% | +437.27% |
Drawdown analysis of Pieris Pharmaceuticals (PIRS)
The maximum drawdown for the PIRS was -99.13%, occurring on Jul 11, 2024. This drawdown has not yet recovered.
The current PIRS drawdown is -98.20%.
Since Apr 13, 2015 PIRS has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 5 times
- 10% or more: 8 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.13% | Feb 13, 2018 | 1611 | Jul 11, 2024 | Ongoing | Ongoing | Ongoing |
| -67.74% | Jun 23, 2015 | 374 | Dec 14, 2016 | 111 | May 25, 2017 | 485 |
| -29.34% | Apr 15, 2015 | 16 | May 7, 2015 | 30 | Jun 19, 2015 | 46 |
| -28.33% | Oct 5, 2017 | 14 | Oct 25, 2017 | 42 | Dec 26, 2017 | 56 |
| -24.05% | Jul 11, 2017 | 23 | Aug 11, 2017 | 35 | Oct 2, 2017 | 58 |
| -14.32% | Jun 2, 2017 | 8 | Jun 14, 2017 | 11 | Jun 29, 2017 | 19 |
| -11.40% | Feb 2, 2018 | 4 | Feb 8, 2018 | 1 | Feb 9, 2018 | 5 |
| -10.71% | Jan 2, 2018 | 9 | Jan 16, 2018 | 8 | Jan 26, 2018 | 17 |
| -5.04% | Jan 26, 2018 | 3 | Jan 31, 2018 | 2 | Feb 2, 2018 | 5 |
| -4.11% | Apr 13, 2015 | 1 | Apr 14, 2015 | 1 | Apr 15, 2015 | 2 |
| -3.15% | May 25, 2017 | 1 | May 26, 2017 | 1 | May 30, 2017 | 2 |
| -1.50% | Dec 26, 2017 | 1 | Dec 27, 2017 | 1 | Dec 28, 2017 | 2 |
| -0.87% | May 30, 2017 | 1 | May 31, 2017 | 1 | Jun 1, 2017 | 2 |
| -0.32% | Oct 2, 2017 | 1 | Oct 3, 2017 | 1 | Oct 4, 2017 | 2 |